|
CN105273045A
|
|
Synthesis and separation identification method for aragatroban related substances
|
|
CN105175329A
|
|
New synthesis route and method of bedaquiline racemate
|
|
CN105272898A
|
|
Novel method for preparing levetiracetam
|
|
CN105272897A
|
|
Levetiracetam preparation method
|
|
CN105272854A
|
|
Preparation method of gefarnate
|
|
CN105085526A
|
|
Improved sildenafil preparation method
|
|
CN105085323A
|
|
Novel synthesis process of Darunavir intermediate
|
|
CN105085524A
|
|
Preparation method of high purity valganciclovir hydrochloride
|
|
CN104434868A
|
|
Stable droxidopa oral dosage form facilitating alimentary canal dissolution
|
|
CN104230798A
|
|
Preparation method of high-purity rebamipide
|
|
CN104230877A
|
|
Preparation method of L-(S)-glyceraldehyde acetonide, and application of L-(S)-glyceraldehyde acetonide in side-chain synthesis of darunavir
|
|
CN104230823A
|
|
Preparation method for gefitinib
|
|
CN104177252A
|
|
Refining purification method of pranlukast intermediate benzyl butyl phenolate acid
|
|
CN104177505A
|
|
Polysaccharide iron complex separating and purifying method
|
|
CN104163825A
|
|
Improved methylboronic acid preparation method
|
|
CN104163806A
|
|
Preparation method of triacetylglucal
|
|
CN104163782A
|
|
Preparation method of 3,4-substitituted thiobenzamide and application of 3,4-substitituted thiobenzamide in febuxostat synthesis
|
|
CN104163855A
|
|
Separation and purification method for caspofungin intermediate and salts thereof
|
|
CN104163811A
|
|
New method for preparation of duloxetine hydrochloride
|
|
CN104000781A
|
|
Anthracycline liposome and preparing method thereof
|
